loadpatents
name:-0.014445066452026
name:-0.02103590965271
name:-0.001262903213501
Wermuth; Camille Georges Patent Filings

Wermuth; Camille Georges

Patent Applications and Registrations

Patent applications and USPTO patent grants for Wermuth; Camille Georges.The latest application filed is for "cyclic-alkylamine derivatives as inhibitors of the interaction between mdm2 and p53".

Company Profile
0.23.16
  • Wermuth; Camille Georges - Strasbourg FR
  • Wermuth; Camille Georges - Illkirch FR
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Inhibitors of the interaction between MDM2 and P53
Grant 8,404,683 - Lacrampe , et al. March 26, 2
2013-03-26
Cyclic-alkylamine derivatives as inhibitors of the interaction between MDM2 and P53
Grant 8,377,961 - Lacrampe , et al. February 19, 2
2013-02-19
Cyclic-alkylamine Derivatives As Inhibitors Of The Interaction Between Mdm2 And P53
App 20120071508 - Lacrampe; Jean Fernand Armand ;   et al.
2012-03-22
Cyclic-alkylamine derivatives as inhibitors of the interaction between MDM2 and p53
Grant 8,088,795 - Lacrampe , et al. January 3, 2
2012-01-03
6-heteroarylpyridoindolone derivatives, their preparation and therapeutic use thereof
Grant 8,063,061 - Muneaux , et al. November 22, 2
2011-11-22
Styrlyquinolines, Their Process Of Preparation And Their Therapeutic Uses
App 20110224242 - Giethlen; Bruno ;   et al.
2011-09-15
Pyridoindolone derivatives substituted in the 3-position by a phenyl, their preparation and their application in therapeutics
Grant 8,012,991 - Bourrie , et al. September 6, 2
2011-09-06
Inhibitors of the Interaction Between MDM2 and P53
App 20110053937 - Lacrampe; Jean Fernand Armand ;   et al.
2011-03-03
Inhibitors of the interaction between MDM2 and p53
Grant 7,834,016 - Lacrampe , et al. November 16, 2
2010-11-16
6-substituted pyridoindolone derivatives, production and therapeutic use thereof
Grant 7,812,165 - Bourrie , et al. October 12, 2
2010-10-12
Cyclic-alkylamine Derivatives As Inhibitors Of The Interaction Between Mdm2 And P53
App 20100168163 - Lacrampe; Jean Fernand Armand ;   et al.
2010-07-01
Piperidin-2, 6-dione pamoate salts and their use for the treatment of affective disorders
App 20090182012 - Wermuth; Camille Georges
2009-07-16
Piperidin-2,6-dione pamoate salts and their use for the treatment of stress-related affective disorders
Grant 7,514,454 - Wermuth April 7, 2
2009-04-07
Derivatives of glycinergic R(+)-2-amino-3-hydroxypropanoic acid
Grant 7,488,755 - Clarence-Smith , et al. February 10, 2
2009-02-10
6-Heteroarylpyridoindolone Derivatives, Their Preparation and Therapeutic Use Thereof
App 20080262020 - MUNEAUX; Yvette ;   et al.
2008-10-23
Pyridoindolone Derivatives Substituted in the 3-Position by a Phenyl, Their Preparation and Their Application in Therapeutics
App 20080214538 - Bourrie; Bernard ;   et al.
2008-09-04
Pyridoindolone derivatives substituted in the 3-position by a phenyl, their preparation and their application in therapeutics
Grant 7,390,818 - Bourrie , et al. June 24, 2
2008-06-24
Derivatives of 14.15-dihydro 20.21-dinoreburnamenin-14-ol and applications thereof
Grant 7,354,918 - Ciapetti , et al. April 8, 2
2008-04-08
Novel Pyrrolodihydroisoquinolines
App 20080064714 - Vennemann; Matthias ;   et al.
2008-03-13
Inhibitors of the Interaction Between Mdm2 and P53
App 20080039472 - Lacrampe; Jean Fernand Armand ;   et al.
2008-02-14
6-Substituted pyridoindolone derivatives, production and therapeutic use thereof
App 20070129365 - Bourrie; Bernard ;   et al.
2007-06-07
Derivatives of 14.15-dihydro 20.21-dinoreburnamenin-14-ol, and applications thereof
App 20070088046 - Ciapetti; Paola ;   et al.
2007-04-19
Piperidin-2,6-dione pamoate salts and their use for the treatment of stress-related affective disorders
App 20060025443 - Wermuth; Camille Georges
2006-02-02
Pyridoindolone derivatives substituted in the 3-position by a phenyl, their preparation and their application in therapeutics
App 20050288318 - Bourrie, Bernard ;   et al.
2005-12-29
Derivatives of glycinergic r(+)-2-amino-3-hydroxypropanoic acid
App 20050261372 - Clarence-Smith, Kathleen ;   et al.
2005-11-24
2-(3-Aminoaryl)amino-4-aryl-thiazoles for the treatment of diseases
App 20040110810 - Ciufolini, Marco ;   et al.
2004-06-10
Aminothiazole derivatives, process for preparing them and pharmaceutical compositions containing them
App 20020137740 - Fontaine, Evelyne ;   et al.
2002-09-26
2-naphthamide derivatives and their therapeutic applications
Grant 5,985,895 - Wermuth , et al. November 16, 1
1999-11-16
Substituted 4-phenylaminothiazoles, their process of preparation and the pharmaceutical compositions containing them
Grant 5,880,135 - Gully , et al. March 9, 1
1999-03-09
2-Naphthamide derivatives and their therapeutic applications
Grant 5,872,119 - Wermuth , et al. February 16, 1
1999-02-16
Pyridazine derivatives
Grant 5,656,631 - Boigegrain , et al. August 12, 1
1997-08-12
Pharmaceutical compounds
Grant 5,589,501 - Carrera , et al. December 31, 1
1996-12-31
Compounds having an aryltriazine structure
Grant 5,254,548 - Wermuth , et al. October 19, 1
1993-10-19
Pyridazine derivatives active on the central nervous system, and medicaments in which they are present
Grant 4,721,711 - Chambon , et al. January 26, 1
1988-01-26
Pyridazine derivatives having a psychotropic action and compositions
Grant 4,565,814 - Kan , et al. January 21, 1
1986-01-21
Aminated derivatives of pyridazine substituted in 6 position by a heterocycle or an alicycle and compositions, said derivatives being active on the central nervous system
Grant 4,524,070 - Kan , et al. June 18, 1
1985-06-18
O-aminoalkyl oximes
Grant 4,038,317 - Wermuth , et al. July 26, 1
1977-07-26

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed